AI-generated summary
The authors studied 14 adults with mild to severe psoriatic plaques treated with a 355 nm UVA1 laser over up to 12 sessions. They report that PASI scores fell from a baseline of 24.5 to 5.8 at three weeks, that all patients were very satisfied, and that no side effects were seen. The study was small and the authors say larger clinical trials are needed.
- Participants
- 14
- Who or what was studied
- Fourteen adults aged 25 to 50 with mild-to-severe psoriatic plaques
- Wavelengths
- 355, 1064, 808 nm
- Limits stated in the abstract
- The authors state that the study was small and that larger clinical trials are needed to confirm the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 355 nm, 808 nm
- Energy density (fluence)
- 140 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.